External Content

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

PARIS (Reuters) - France has started measures to suspend sales of a product known as Uvesterol D, used for Vitamin D deficiency, after the death of a baby who had been given a dose of it, a French medical safety watchdog said on Wednesday.

"The conclusions of investigations so far show evidence pointing to a probable link between the death, and the dose of Uvesterol D that was administered," the medical safety agency ANSM said in a statement.

Uvesterol D is developed by the Crinex laboratory.

Officials at Crinex could not be immediately reached for comment.

(Reporting by Sudip Kar-Gupta and Eric Faye; Editing by Robert Birsel)

Neuer Inhalt

Horizontal Line


subscription form

Form for signing up for free newsletter.

Sign up for our free newsletters and get the top stories delivered to your inbox.







Click here to see more newsletters

swissinfo EN

The following content is sourced from external partners. We cannot guarantee that it is suitable for the visually or hearing impaired.

Join us on Facebook!

Reuters